From July 20 to 21 and 24 to 26, the PMDA held a five-day seminar entitled “PMDA-ATC Pharmaceuticals Review Seminar for JICA trainees 2023” in collaboration with the Japan International Cooperation Agency (JICA). Six people from six countries (Bangladesh, Brazil, Egypt, Indonesia, Laos, and Timor-Leste) participated in the seminar. On the first and second days, the trainees visited the Exhibition Room for Remembrance of History of Drug-induced Suffering in the PMDA Tokyo office and were given an overview of the PMDA, approval review in Japan, safety measures, and GCP/GLP inspections. From the third day, they moved to Toyama Prefecture, where the PMDA Hokuriku branch was located, learned about pharmaceutical administration in local governments and GMP management, and went around site tours. The site tour included visits to manufacturing facilities in cooperation with Teika Pharmaceutical Co., Ltd. and TOA Pharmaceuticals Co., Ltd., as well as visits to the Toyama Prefectural Institute for Pharmaceutical Research and Medicinal Plants Center in cooperation with the Toyama Prefectural Government.
See attached program